Adipotide: research, legal status and who sells it
This page is information, not medical advice. Adipotide is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- FTPP, CKGGRAKDC-GG-D(KLAKLAK)2
- Category
- Synthetic peptidomimetic designed to target blood vessels in white fat
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $4.16/mg to $17.50/mg, median $10.15/mg across 14 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains adipotide [1]. |
| United Kingdom | No UK-licensed medicine containing adipotide appears in the MHRA products database [2]. |
| European Union | No medicine containing adipotide is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing adipotide appears in Health Canada's Drug Product Database [5]. |
| Australia | Adipotide is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of Adipotide yet. The legal status table and live prices on this page are current.
Adipotide prices: cheapest listings
The five lowest $/mg listings out of 20. See all Adipotide prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Chimera Peptides | 27 | 5 mg × 10 | $208 | $4.16/mg | View | ||
| Geo Peptides | 52 | 5 mg | $26 | $5.20/mg | View | ||
| Chimera Peptides | 27 | 2 mg × 10 | $121 | $6.05/mg | View | ||
| Peptide Pros | 58 | 10 mg | $73 | $7.30/mg | View | ||
| Pure Peptide Labs | 90 | 10 mg | $75 | $7.50/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "adipotide". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Science Translational Medicine (2011). Accessed Oct 15, 2026